The nation's largest commercial health insurer is pausing implementation until "at least the end of the national public health emergency period," the organization said recently.

The Medical Imaging Drugs Advisory Committee reviews data on radiopharmaceuticals and contrast media, recommending best practices to the agency's commissioner.

The nation's largest commercial insurer recently started forcing physicians to jump through extra hoops before getting paid for certain outpatient services. 

Alzheimer's patients will need to have a brain scan showing the presence of beta-amyloid in order to receive Biogen's Aduhelm (aducanumab) treatment, yet Medicare doesn't cover such exams.

Absent passage of HR 3657, the profession is “in peril,” with RAs losing their jobs and left unable to practice to the full extent of their training, advocates said. 

The two tech giants have now cleared a key hurdle to completing their merger, company officials revealed recently. 

Pylarify is a F 18-labeled, prostate-specific membrane antigen targeted PET agent used to pinpoint suspected metastasis or recurrence of the disease. 

Most nonhospital-based groups fall outside of the new CMS rule, but there’s still an opportunity to adopt this mindset and attract new customers, experts wrote recently.